Results about: metastasis dormancy

<p>Gomis</p>

Intricate signalling networks control cell division, differentiation, movement, organization and death. Understanding how cells read and transform these signals into changes in cell behaviour is a major research focus of our group.

“Questions are raised when dealing with patients, but are answered in the laboratory.”

Juan Miguel Cejalvo (Valencia, 1984), an oncologist trained at the Hospital Clínico Universitario de Valencia, has been selected to do his thesis at IRB Barcelona under the PhD for Medical Doctors (PhD4MD) programme. He has already joined Roger Gomis’ Growth Control and Cancer Metastasis group, where he will perform the basic research for his project. Aleix Prat, from IDIBAPS, will lead the clinical part of this project. Both Roger Gomis and Aleix Prat have extensive experience in cancer research, especially breast cancer and metastasis. Promoted by IRB Barcelona, CRG, IDIBAPS and VHIR, the PhD4MD programme seeks to train a new generation of physician-scientists in order to facilitate the transfer of biomedical discoveries to patients.

Worldwide Cancer Research award goes to an IRB Barcelona project on breast cancer metastasis

This June, Roger Gomis will start a study on a protein that confers tumour cells the capacity to colonise and to become resistant to treatment.

The international charity has awarded funding to 27 of the more than 700 projects presented.